[18F]fluoropyridines: From conventional radiotracers to the labeling of macromolecules such as proteins and oligonucleotides.

[1]  David W. Townsend,et al.  Positon emission tomography: basic science and clinical practice , 2008 .

[2]  F. Dollé,et al.  Synthesis and radiosynthesis of [18F]FPhEP, a novel α4β2-selective, epibatidine-based antagonist for PET imaging of nicotinic acetylcholine receptors , 2006 .

[3]  P. Gmeiner,et al.  Synthesis and evaluation of 18F-labeled dopamine D3 receptor ligands as potential PET imaging agents. , 2005, Bioorganic & medicinal chemistry letters.

[4]  Yiyun Huang,et al.  Epibatidine analogues as selective ligands for the αxβ2-containing subtypes of nicotinic acetylcholine receptors , 2005 .

[5]  F. Jessen,et al.  A simple and fast method for the preparation of n.c.a. 2-[18F]F-A85380 for human use. , 2005, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[6]  F. Dollé.  Fluorine-18-labelled fluoropyridines: advances in radiopharmaceutical design. , 2005, Current pharmaceutical design.

[7]  Christopher C Rowe,et al.  Simplified quantification of nicotinic receptors with 2[18F]F-A-85380 PET. , 2005, Nuclear medicine and biology.

[8]  A. Syrota,et al.  Acute effects of physostigmine and galantamine on the binding of [18F]fluoro‐A‐85380: A PET study in monkeys , 2005, Synapse.

[9]  R. Boisgard,et al.  In vivo biodistribution and pharmacokinetics of 18F-labelled Spiegelmers: a new class of oligonucleotidic radiopharmaceuticals , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[10]  R. Dorr,et al.  Synthesis of [14C]‐imexon , 2005 .

[11]  R. Boisgard,et al.  1-[3-(2-[18F]fluoropyridin-3-yloxy)propyl]pyrrole-2,5-dione: design, synthesis, and radiosynthesis of a new [18F]fluoropyridine-based maleimide reagent for the labeling of peptides and proteins. , 2005, Bioconjugate chemistry.

[12]  Jean-Dominique Gallezot,et al.  In vivo imaging of human cerebral nicotinic acetylcholine receptors with 2-18F-fluoro-A-85380 and PET. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  E. London,et al.  In vitro characterization of 6‐[18F]fluoro‐A‐85380, a high‐affinity ligand for α4β2* nicotinic acetylcholine receptors , 2005 .

[14]  Edythe D London,et al.  Pharmacological and Toxicological Evaluation of 2-Fluoro-3-(2(S)-azetidinylmethoxy)pyridine (2-F-A-85380), a Ligand for Imaging Cerebral Nicotinic Acetylcholine Receptors with Positron Emission Tomography , 2005, Journal of Pharmacology and Experimental Therapeutics.

[15]  P. Falkai,et al.  Imaging of central nAChReceptors with 2-[18F]F-A85380: optimized synthesis and in vitro evaluation in Alzheimer's disease. , 2004, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[16]  A. Horti,et al.  Synthesis of 6‐chloro‐3‐((2‐(S)‐azetidinyl)methoxy)‐5‐(2‐[18F]fluoropyridin‐4‐yl)pyridine ([18F]NIDA 522131), a novel potential radioligand for studying extrathalamic nicotinic acetylcholine receptors by PET , 2004 .

[17]  Jörg Steinbach,et al.  Norchloro-fluoro-homoepibatidine: specificity to neuronal nicotinic acetylcholine receptor subtypes in vitro. , 2004, Farmaco.

[18]  N. Volkow,et al.  6‐[18F]Fluoro‐A‐85380, a new PET tracer for the nicotinic acetylcholine receptor: Studies in the human brain and in vivo demonstration of specific binding in white matter , 2004, Synapse.

[19]  A. Horti,et al.  Efficient synthesis of 6-chloro-3-((2-(S)-azetidinyl)methoxy)-5-((E)-2-(2-[18F]fluoropyridin-4-yl)vinyl)pyridine ([18F]NIDA 52289), a very high affinity radioligand for nicotinic acetylcholine receptors , 2004 .

[20]  B. Tavitian,et al.  Design and synthesis of a new [18F]fluoropyridine-based haloacetamide reagent for the labeling of oligonucleotides: 2-bromo-N-[3-(2-[18F]fluoropyridin-3-yloxy)propyl]acetamide. , 2004, Bioconjugate chemistry.

[21]  A. Horti,et al.  5-substituted derivatives of 6-halogeno-3-((2-(S)-azetidinyl)methoxy)pyridine and 6-halogeno-3-((2-(S)-pyrrolidinyl)methoxy)pyridine with low picomolar affinity for alpha4beta2 nicotinic acetylcholine receptor and wide range of lipophilicity: potential probes for imaging with positron emission tomog , 2004, Journal of medicinal chemistry.

[22]  J. Bénavidès,et al.  Synthesis of a [2-pyridinyl-18F]-labelled fluoro derivative of (-)-cytisine as a candidate radioligand for brain nicotinic alpha4beta2 receptor imaging with PET. , 2003, Bioorganic & medicinal chemistry.

[23]  R. Boisgard,et al.  Fluorine‐18‐ and iodine‐125‐labelling of spiegelmers , 2003 .

[24]  R. Boisgard,et al.  Fluorine‐18 labelling of oligonucleotides: Prosthetic labelling at the 5′‐end using the N‐(4‐[18F]fluorobenzyl)‐2‐bromoacetamide reagent , 2003 .

[25]  F. Dollé,et al.  2-, 3- and 4-[18F]Fluoropyridine by no-carrier-added nucleophilic aromatic substitution with K[18F]F-K222- a comparative study: 2-, 3- and 4-[18F] FLUOROPYRIDINE , 2003 .

[26]  B. Tavitian,et al.  Modulation of the pharmacokinetic properties of PNA: preparation of galactosyl, mannosyl, fucosyl, N-acetylgalactosaminyl, and N-acetylglucosaminyl derivatives of aminoethylglycine peptide nucleic acid monomers and their incorporation into PNA oligomers. , 2003, Bioconjugate chemistry.

[27]  C. Halldin,et al.  Synthesis of a [6-pyridinyl-18F]-labelled fluoro derivative of WAY-100635 as a candidate radioligand for brain 5-HT1A receptor imaging with PET. , 2003, Bioorganic & medicinal chemistry.

[28]  Monique Ernst,et al.  2 [18F]F‐A85380: PET imaging of brain nicotinic acetylcholine receptors and whole body distribution in humans , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  B. Tavitian.  In vivo imaging with oligonucleotides for diagnosis and drug development , 2003, Gut.

[30]  L. Barré,et al.  Synthesis and biological evaluation of halogenated naphthyridone carboxamides as potential ligands for in vivo imaging studies of substance P receptors. , 2003, Bioconjugate chemistry.

[31]  Edythe D London,et al.  Graphical analysis of 2‐[18F]FA binding to nicotinic acetylcholine receptors in rhesus monkey brain , 2003, Synapse.

[32]  Marcel Ricard,et al.  Biodistribution and radiation dosimetry of 18F-fluoro-A-85380 in healthy volunteers. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[33]  B. Kaina,et al.  Synthesis of 2‐Amino‐6‐(2‐ [18F] fluoro‐pyridine‐4‐ylmethoxy)‐9‐(octyl‐β‐D‐glucosyl)‐purine: A Novel Radioligand for Positron Emission Tomography Studies of the O6‐Methylguanine‐DNA Methyltransferase (MGMT) Status of Tumor Tissue. , 2002 .

[34]  A. Syrota,et al.  Long‐lasting occupancy of central nicotinic acetylcholine receptors after smoking: a PET study in monkeys , 2002, Journal of neurochemistry.

[35]  M. Welch,et al.  Handbook of Radiopharmaceuticals: Radiochemistry and Applications , 2002 .

[36]  I. al-jammaz,et al.  Novel synthesis of 2-[18F]-fluoroisonicotinic acid hydrazide and initial biological evaluation. , 2002, Nuclear medicine and biology.

[37]  F. Dollé,et al.  Fluoro-A-85380 demonstrated no mutagenic properties in in vivo rat micronucleus and Ames tests. , 2002, Nuclear medicine and biology.

[38]  D. Labaree,et al.  Synthesis of halogen-substituted pyridyl and pyrimidyl derivatives of [3,2-c]pyrazolo corticosteroids: strategies for the development of glucocorticoid receptor mediated imaging agents. , 2002, Journal of medicinal chemistry.

[39]  B. Kaina,et al.  Synthesis of 2-amino-6-(2-[18F]fluoro-pyridine-4-ylmethoxy)-9-(octyl-β-d-glucosyl)-purine: a novel radioligand for positron emission tomography studies of the O6-methylguanine-DNA methyltransferase (MGMT) status of tumour tissue , 2002 .

[40]  Raphaël Boisgard,et al.  Labelled oligonucleotides as radiopharmaceuticals: pitfalls, problems and perspectives. , 2002, Current pharmaceutical design.

[41]  S. Klußmann,et al.  In vivo properties of an anti-GnRH Spiegelmer: An example of an oligonucleotide-based therapeutic substance class , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[42]  B. Tavitian,et al.  Characterization of a Synthetic Anionic Vector for Oligonucleotide Delivery Using in Vivo Whole Body Dynamic Imaging , 2002, Pharmaceutical Research.

[43]  H. VanBrocklin,et al.  Photoconjugation of 3-azido-5-nitrobenzyl-[18F]fluoride to an oligonucleotide aptamer , 2002 .

[44]  B. Kaina,et al.  An approach to the evaluation of the activity of the DNA repair enzyme O6-methylguanine-DNA-methyl-transferase in tumor tissue in vivo: syntheses of 6-benzyloxy-9-(2-[18F]fluoroethyl)-9H-purin-2-yl-amine and 6-benzyloxy-7-(2-[18F]fluoroethyl)-7H-purin-2-yl-amine. , 2002, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[45]  L. Brieaddy,et al.  Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2'-substituted-3'-phenyl-5'-pyridinyl)-7-azabicyclo[2.2.1]heptanes. Novel nicotinic antagonist. , 2001, Journal of medicinal chemistry.

[46]  E. London,et al.  5-IODO-6-[18F]fluoro-3-(2(S)-azetidinylmethoxy)pyridine, a novel pet radioligand for nicotinic acetylcholine receptors: Synthesis and initial evaluation , 2001 .

[47]  L. Barré,et al.  Synthesis and radiosynthesis with a positron emitter of EP 00652218, a potent antagonist of NK1 receptor, and of a fluoro analog for in vivo evaluation of the substance P receptor by pet , 2001 .

[48]  Okarvi Sm,et al.  Recent progress in fluorine-18 labelled peptide radiopharmaceuticals , 2001 .

[49]  H. Wikström,et al.  New halogenated [11C]WAY analogues, [11C]6FPWAY and [11C]6BPWAY--radiosynthesis and assessment as radioligands for the study of brain 5-HT1A receptors in living monkey. , 2001, Nuclear medicine and biology.

[50]  M. K. O'brien,et al.  Efficient synthesis of AMP579, a novel adenosine A1/A2 receptor agonist. , 2000, The Journal of organic chemistry.

[51]  C. Crouzel,et al.  General method to label antisense oligonucleotides with radioactive halogens for pharmacological and imaging studies. , 2000, Bioconjugate chemistry.

[52]  L. Chan,et al.  Design and evaluation of dihydroisoquinolines as potent and orally bioavailable human cytomegalovirus inhibitors. , 2000, Bioorganic & medicinal chemistry letters.

[53]  R. S. Matthews,et al.  19F NMR spectroscopy of polyhalonaphthalenes , 2000 .

[54]  C. Crouzel,et al.  Fluorine-18 labeling of oligonucleotides bearing chemically—modified ribose—phosphate backbones , 2000 .

[55]  J. Links,et al.  6-[18F]fluoro-A-85380, a novel radioligand for in vivo imaging of central nicotinic acetylcholine receptors. , 2000, Life sciences.

[56]  J. Fowler,et al.  Synthesis and evaluation of 6-[(18)F]fluoro-3-(2(S)-azetidinylmethoxy)pyridine as a PET tracer for nicotinic acetylcholine receptors. , 2000, Nuclear medicine and biology.

[57]  N. Volkow,et al.  Dopamine Receptor‐Mediated Regulation of Striatal Cholinergic Activity , 2000, Journal of neurochemistry.

[58]  E. London,et al.  Synthesis and initial in vitro characterization of 6‐[18F]fluoro‐3‐(2(S)‐azetidinylmethoxy)pyridine, a high‐affinity radioligand for central nicotinic acetylcholine receptors , 2000 .

[59]  J. Edwards,et al.  Effects of isosteric pyridone replacements in androgen receptor antagonists based on 1,2-dihydro- and 1,2,3,4-tetrahydro-2,2-dimethyl-6-trifluoromethyl-8-pyridono[5,6-g]quin olines. , 2000, Bioorganic & medicinal chemistry letters.

[60]  K. Yanagi,et al.  Synthesis and reactivity of pyridylpyridone derivatives. , 2000, The Journal of organic chemistry.

[61]  A. Hakura,et al.  Anti-mutagenic structural modification by fluorine-substitution in highly mutagenic 4-methylquinoline derivatives. , 2000, Mutation research.

[62]  E. Pauwels,et al.  18F-labeled radiopharmaceuticals for PET in oncology, excluding FDG. , 2000, Nuclear medicine and biology.

[63]  C. Crouzel,et al.  2‐[18F]fluoropyridines by no‐carrier‐added nucleophilic aromatic substitution with [18F]FK‐K222—a comparative study , 1999 .

[64]  J M Links,et al.  2-[18F]F-A-85380: a PET radioligand for alpha4beta2 nicotinic acetylcholine receptors. , 1999, Neuroreport.

[65]  C Crouzel,et al.  Imaging central nicotinic acetylcholine receptors in baboons with [18F]fluoro-A-85380. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[66]  P. Sapra,et al.  Fluorination of 2-Chloro-3-formylquinolines Using Microwaves. , 1999 .

[67]  C. Crouzel,et al.  In Vivo Imaging and Pharmacokinetics of Oligonucleotides , 1999 .

[68]  C Crouzel,et al.  Synthesis and nicotinic acetylcholine receptor in vivo binding properties of 2-fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine: a new positron emission tomography ligand for nicotinic receptors. , 1999, Journal of medicinal chemistry.

[69]  C. Crouzel,et al.  Synthesis of a fluorine-18 labeled derivative of epibatidine for in vivo nicotinic acetylcholine receptor PET imaging. , 1999, Bioorganic & medicinal chemistry.

[70]  C. Crouzel,et al.  Characterization of the nicotinic ligand 2-[18F]fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine in vivo. , 1998, Life sciences.

[71]  Stöcklin Gl.  Is there a future for clinical fluorine-18 radiopharmaceuticals (excluding FDG)? , 1998 .

[72]  D. Donnelly-roberts,et al.  Structure-activity studies related to ABT-594, a potent nonopioid analgesic agent: effect of pyridine and azetidine ring substitutions on nicotinic acetylcholine receptor binding affinity and analgesic activity in mice. , 1998, Bioorganic & medicinal chemistry letters.

[73]  E. London,et al.  2-, 5-, and 6-Halo-3-(2(S)-azetidinylmethoxy)pyridines: synthesis, affinity for nicotinic acetylcholine receptors, and molecular modeling. , 1998, Journal of medicinal chemistry.

[74]  R. S. Matthews.  19F NMR spectroscopy of polyhalonaphthalenes. Part IV. Halex reactions of polychloroquinolines , 1998 .

[75]  Xiaodong Wang,et al.  A General Synthesis of 4-Substituted 6-(2-Imidazolinylamino)-5,8-dimethylquinolines. , 1998, The Journal of organic chemistry.

[76]  N. Volkow,et al.  In Vitro and Ex Vivo Autoradiographic Studies of Nicotinic Acetylcholine Receptors Using [18F]Fluoronorchloroepibatidine in Rodent and Human Brain , 1998 .

[77]  C. Crouzel,et al.  Synthesis of 2‐[18F]fluoro‐3‐[2(S)‐2‐azetidinylmethoxy]pyridine, a highly potent radioligand for in vivo imaging central nicotinic acetylcholine receptors , 1998 .

[78]  Bernard Bendriem,et al.  In vivo imaging of oligonucleotides with positron emission tomography , 1998, Nature Medicine.

[79]  John L. Musachio,et al.  Synthesis of a radiotracer for studying nicotinic acetylcholine receptors: 2-[18F]fluoro-3-(2(S)-azetidinylmethoxy)pyridine (2-[18F]A-85380) , 1998 .

[80]  D. Donnelly-roberts,et al.  Identification and initial structure-activity relationships of (R)-5-(2-azetidinylmethoxy)-2-chloropyridine (ABT-594), a potent, orally active, non-opiate analgesic agent acting via neuronal nicotinic acetylcholine receptors. , 1998, Journal of medicinal chemistry.

[81]  J S Fowler,et al.  Fluoro-norchloroepibatidine: preclinical assessment of acute toxicity. , 1997, Nuclear medicine and biology.

[82]  E. London,et al.  Imaging nicotinic acetylcholine receptors with fluorine-18-FPH, an epibatidine analog. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[83]  J. Fowler,et al.  Synthesis of [18F]norchlorofluoroepibatidine and its N-methyl derivative: new PET ligands for mapping nicotinic acetylcholine receptors , 1997 .

[84]  E. London,et al.  Fluorine-18-FPH for PET imaging of nicotinic acetylcholine receptors. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[85]  N. Volkow,et al.  Synthesis and nicotinic acetylcholine receptor binding properties of exo-2-(2'-fluoro-5'-pyridinyl)-7-azabicyclo-[2.2.1]heptane: a new positron emission tomography ligand for nicotinic receptors. , 1997, Journal of medicinal chemistry.

[86]  C. Crouzel,et al.  A general method for labeling oligodeoxynucleotides with 18F for in vivo PET imaging , 1997 .

[87]  N. Volkow,et al.  Mapping nicotinic acetylcholine receptors with PET , 1996, Synapse.

[88]  Volker A. Erdmann,et al.  Mirror-design of L-oligonucleotide ligands binding to L-arginine , 1996, Nature Biotechnology.

[89]  D. Donnelly-roberts,et al.  A-85380 [3-(2(S)-azetidinylmethoxy) pyridine]: In Vitro pharmacological properties of a novel, high affinity α4β2 nicotinic acetylcholine receptor ligand , 1996, Neuropharmacology.

[90]  W. Denny,et al.  Tyrosine kinase inhibitors. 10. Isomeric 4-[(3-bromophenyl)amino]pyrido[d]-pyrimidines are potent ATP binding site inhibitors of the tyrosine kinase function of the epidermal growth factor receptor. , 1996, Journal of medicinal chemistry.

[91]  E. London,et al.  Synthesis of a radiotracer for studying nicotinic acetylcholine receptors : (+/−)-exo-2-(2-[18F]fluoro-5-pyridyl)-7-azabicyclo[2.2.1]heptane , 1996 .

[92]  D. Donnelly-roberts,et al.  Novel 3-Pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors. , 1996, Journal of medicinal chemistry.

[93]  S. Ametamey,et al.  Comparison of two synthetic methods to obtain [18F] N-(2-aminoethyl)-5-fluoropyridine-2-carboxamide, a potential MAO-B imaging tracer for PET , 1995 .

[94]  M. Egholm,et al.  Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide. , 1991, Science.

[95]  A. Scott,et al.  An improved procedure for the synthesis of DL‐[2‐13C]‐glutamic acid , 1990 .

[96]  J. Matsumoto,et al.  Pyridonecarboxylic Acids as Antibacterial Agents. Part 10. Synthesis and Reactions of 7-Substituted 1-Cyclopropyl-6-fluoro-1,4-dihydro-4- oxo-1,8-naphthyridine-3-carboxylic Acids as an Antibacterial Agent. , 1988 .

[97]  H. Egawa,et al.  Synthesis and reactions of 7-substituted 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acids as an antibacterial agent† , 1987 .

[98]  C. Dence,et al.  Fluorine-18 labeling of proteins. , 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[99]  H. Coenen,et al.  Preparation of N.C.A. [17‐18F]‐fluoroheptadecanoic acid in high yields via aminopolyether supported, nucleophilic fluorination , 1986 .

[100]  K. Hamacher,et al.  Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[101]  V. M. Vlasov,et al.  Interaction of chloroaromatic compounds with alkali metal fluorides in the presence of crown-ethers , 1985 .

[102]  J. Ballinger,et al.  Radiofluorination with reactor-produced cesium [18F]fluoride: no-carrier-added [18F]2-fluoronicotine and [18F]6-fluoronicotine , 1984 .

[103]  G. Stöcklin,et al.  Production of Some Medically Important Short-Lived Neutron-Deficient Radioisotopes of Halogens , 1983 .

[104]  M. Schüller,et al.  Synthesis, quality control and tissue distribution of 2-[18F]-nicotinic acid diethylamide, a potential agent for regional cerebral function studies , 1982 .

[105]  J. Hitzke.  FLUORINATION OF HEXACHLOROBENZENE AND PENTACHLOROPYRIDINE IN A MEDIUM OF SOLID POTASSIUM FLUORIDE , 1980 .

[106]  J. Hitzke.  La fluoration de l'hexachlorobenzene et de la pentachloropyridine en milieu de fluorure de potassium solide , 1980 .

[107]  Jerry March,et al.  Advanced Organic Chemistry: Reactions, Mechanisms, and Structure , 1977 .

[108]  H. S. Gutowsky,et al.  Aromatic Fluorine Compounds. XI. Replacement of Chlorine by Fluorine in Halopyridines , 1963 .

[109]  L. Brieaddy,et al.  Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 3'-substituted deschloroepibatidine analogues. Novel nicotinic antagonists. , 2005, Journal of medicinal chemistry.

[110]  R. Boisgard,et al.  Fluorine‐18 labelling of PNAs functionalized at their pseudo‐peptidic backbone for imaging studies with PET , 2005 .

[111]  B. Tavitian.  Oligonucleotides as radiopharmaceuticals. , 2005, Ernst Schering Research Foundation workshop.

[112]  P. Nielsen.  Peptide nucleic acids : protocols and applications , 2004 .

[113]  H. Wikström,et al.  The pyridinyl-6 position of WAY-100635 as a site for radiofluorination--effect on 5-HT1A receptor radioligand behavior in vivo. , 2004, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.

[114]  B. Tavitian,et al.  Fluorine-18 labeling of peptide nucleic acids , 2002 .

[115]  C. Crouzel,et al.  Chemistry of β +-Emitting Compounds Based on Fluorine-18 , 2002 .

[116]  L. Brieaddy,et al.  Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2'-substituted 5'-pyridinyl)-7-azabicyclo[2.2.1]heptanes. Epibatidine analogues. , 2001, Journal of medicinal chemistry.

[117]  J S Fowler,et al.  Comparative studies of epibatidine derivatives [18F]NFEP and [18F]N-methyl-NFEP: kinetics, nicotine effect, and toxicity. , 1999, Nuclear medicine and biology.

[118]  M. Kidwai,et al.  Rapid Side-chain Chlorination of Heterocyclic Compounds using Focused Microwave Irradiation , 1998 .

[119]  B. Långstrom,et al.  F-18-labelling of oligonucleotides using succinimido 4-[F-18]fluorobenzoate , 1998 .

[120]  E. London,et al.  2-[18F]Fluoro-A-85380, an in vivo tracer for the nicotinic acetylcholine receptors. , 1998, Nuclear medicine and biology.

[121]  B. Långstrom,et al.  Synthesis of 4-([F-18]fluoromethyl)phenyl isothiocyanate and its use in labelling oligonucleotides , 1997 .

[122]  Victor W. Pike,et al.  Radiopharmaceuticals for Positron Emission Tomography , 1993, Developments in Nuclear Medicine.

[123]  P. Hradil,et al.  Synthesis of some 1-alkyl-1,4-dihydro-4-oxo-1,7-naphthyridine-3-carboxylic acids , 1991 .

[124]  J. Clark,et al.  The synthesis of organofluorine compounds using potassium fluoride-tetraphenylphosphonium bromide systems , 1987 .

[125]  M. Welch,et al.  Fluorine-18 labeled receptor based radiopharmaceuticals. , 1986, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.

[126]  N. Peet,et al.  Reinvestigation of a cyclization reaction of 2-hydrazino-3-(1H-pyrrol-1-yl)pyridine , 1986 .

[127]  Richard B. Firestone,et al.  Table of Isotopes , 1978 .

[128]  F. Naso,et al.  Fluorodenitration of some mildly activated nitro-compounds , 1972 .